What did @justagrownwoman actually say?
She recommended looking into Thymosin Alpha-1, Thymosin Beta-4, BPC-157, and "L37" as peptides worth researching if you have Hashimoto's thyroiditis. She framed it carefully, saying "I'm not your doctor" and acknowledging that many of these peptides are "labeled research only." She stopped short of claiming any of them would treat or reverse the condition, but the implicit message was clear: these peptides could plausibly help with an autoimmune thyroid disease. That framing matters, because implied recommendations carry real weight with 43,800 viewers.
She also said you are your own "guinea pig," which is at least honest about the experimental nature of what she's describing. That's more candor than most peptide creators offer. Still, naming specific peptides for a specific disease without clinical evidence to back it up is where this video starts to wobble.
Does the science back this up?
For Thymosin Alpha-1 and BPC-157, there is legitimate preclinical interest. For Thymosin Beta-4 in Hashimoto's specifically, the evidence is thin. For "L37," the identity of this peptide is unclear enough that it's essentially unverifiable.
Thymosin Alpha-1 (Ta1) has the strongest case here. It is an immune-modulating peptide with documented effects on T-regulatory cell function. A 2012 study by Garaci et al. in Annals of the New York Academy of Sciences documented its immunomodulatory properties in autoimmune contexts. Hashimoto's is driven by aberrant T-cell activity attacking thyroid tissue, so the mechanistic logic exists, but human trials specifically in Hashimoto's patients are essentially absent from the published literature.
BPC-157 has shown anti-inflammatory effects in rodent models, particularly in gut and connective tissue repair. Sikiric et al. have published extensively on BPC-157 in the Journal of Physiology Paris, but none of this work directly addresses thyroid autoimmunity. Extrapolating from rat gut studies to human autoimmune thyroid disease is a significant leap.
Thymosin Beta-4 has regenerative and anti-inflammatory properties documented in wound healing research, but its relevance to Hashimoto's is speculative at best.
What did they get wrong (or right)?
Credit where it is due: the disclaimer was genuine, and the framing around research-only status was accurate. These peptides are not FDA-approved treatments for Hashimoto's. Calling yourself a "guinea pig" is not irresponsible, it is honest. More creators should say it.
What went wrong is the specificity without evidence. Naming four peptides for one condition implies a level of clinical rationale that simply does not exist in the peer-reviewed literature. Thymosin Alpha-1 has the most defensible logic given its T-cell modulating effects, and she listed it first, so partial credit there.
The reference to "L37" is a genuine problem. This does not correspond clearly to any widely recognized peptide in the research literature under that name. It may refer to a fragment or analog, but recommending something you cannot clearly identify by its established scientific name to people managing an autoimmune disease is not a minor slip.
She also did not mention that people with Hashimoto's are often already on levothyroxine or other thyroid medications, and that stacking unregulated peptides with thyroid hormone therapy carries unknown interaction risks. That omission matters.
What should you actually know?
Hashimoto's is a chronic autoimmune condition, not a healing deficit that peptides are designed to address. The peptides mentioned here were mostly studied for tissue repair, immune priming in infectious disease contexts, or general inflammation, not thyroid autoimmunity.
If you have Hashimoto's and are interested in immune-modulating approaches, Thymosin Alpha-1 is the most studied peptide in autoimmune contexts broadly, and some integrative medicine physicians do use it off-label. That does not make it a proven treatment. It makes it an experimental one with a plausible mechanism.
Before adding any peptide to a thyroid condition regimen, your TSH, T3, T4, and TPO antibody levels should be monitored. These are the markers that tell you whether your thyroid function and autoimmune load are actually changing. No peptide content creator on TikTok can track that for you. A physician who specializes in integrative endocrinology or functional medicine can.
Anyone managing Hashimoto's who wants to explore peptide therapy should do so through a licensed telehealth or clinic provider who can order labs, monitor thyroid markers, and adjust medications accordingly.